• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲弗赫特河药物对人类健康风险评估。

Human health risk assessment of pharmaceuticals in the European Vecht River.

机构信息

Department of Environmental Science, Institute for Water & Wetland Research, Radboud University Nijmegen, Nijmegen, The Netherlands.

Department of Global Health-Amsterdam, Institute for Global Health and Development, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

出版信息

Integr Environ Assess Manag. 2022 Nov;18(6):1639-1654. doi: 10.1002/ieam.4588. Epub 2022 Feb 28.

DOI:10.1002/ieam.4588
PMID:35112470
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9790459/
Abstract

Active pharmaceutical ingredients (APIs) can reach surface waters used for drinking water extraction and recreational activities, such as swimming and fishing. The aim of the present study was to systematically assess the lifetime human health risks posed by 15 individual APIs and their mixtures occurring in the German-Dutch transboundary Vecht River. An exposure model was developed and used to assess the combined risks of oral and dermal exposure under a variety of exposure conditions. A total of 4500 API uptake values and 165 lifetime risk values were estimated for 15 and 11 APIs, respectively. Overall, the lifetime human health risks posed by the APIs and their mixtures based on modeling results were deemed acceptable under typical exposure conditions. Under very extreme environmental conditions and human behavior, API mixture risks were of potential concern while the risks of individual APIs were negligible, with a few exceptions. The antibiotic doxycycline and analgesic phenazone showed the highest and lowest risks, respectively. The study did not evaluate the potential risks caused by metabolite compounds. Recommendations for water managers are provided to help improve the accuracy and utility of human health risk assessments of pharmaceuticals. Integr Environ Assess Manag 2022;18:1639-1654. © 2022 The Authors. Integrated Environmental Assessment and Management published by Wiley Periodicals LLC on behalf of Society of Environmental Toxicology & Chemistry (SETAC).

摘要

活性药物成分 (API) 可能会进入用于饮用水提取和娱乐活动(如游泳和钓鱼)的地表水。本研究的目的是系统评估在德国-荷兰跨界 Vecht 河存在的 15 种单独 API 及其混合物对人类终生健康造成的风险。开发了一种暴露模型,并用于评估在各种暴露条件下口服和皮肤暴露的综合风险。分别为 15 种和 11 种 API 估算了 4500 个 API 摄取值和 165 个终生风险值。总体而言,基于建模结果,在典型暴露条件下,API 和其混合物对人类健康造成的终生风险被认为是可以接受的。在非常极端的环境条件和人类行为下,API 混合物的风险可能受到关注,而个别 API 的风险可以忽略不计,但也有例外。抗生素强力霉素和止痛药非那宗分别显示出最高和最低的风险。本研究没有评估代谢物化合物可能造成的潜在风险。为了帮助提高药物的人类健康风险评估的准确性和实用性,为水管理者提供了建议。2022 年《综合环境评估与管理》,第 18 卷,第 1639-1654 页。© 2022 作者。综合环境评估与管理由 Wiley 期刊 LLC 代表环境毒理与化学学会(SETAC)出版。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/852c/9790459/92ad4afe946e/IEAM-18-1639-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/852c/9790459/8d52a4ec1b62/IEAM-18-1639-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/852c/9790459/31a24a09af30/IEAM-18-1639-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/852c/9790459/5fbe462ac8ac/IEAM-18-1639-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/852c/9790459/92ad4afe946e/IEAM-18-1639-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/852c/9790459/8d52a4ec1b62/IEAM-18-1639-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/852c/9790459/31a24a09af30/IEAM-18-1639-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/852c/9790459/5fbe462ac8ac/IEAM-18-1639-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/852c/9790459/92ad4afe946e/IEAM-18-1639-g004.jpg

相似文献

1
Human health risk assessment of pharmaceuticals in the European Vecht River.欧洲弗赫特河药物对人类健康风险评估。
Integr Environ Assess Manag. 2022 Nov;18(6):1639-1654. doi: 10.1002/ieam.4588. Epub 2022 Feb 28.
2
Ecological Risk Assessment of Pharmaceuticals in the Transboundary Vecht River (Germany and The Netherlands).跨界河流(德国和荷兰)中药物的生态风险评估。
Environ Toxicol Chem. 2022 Mar;41(3):648-662. doi: 10.1002/etc.5062. Epub 2021 May 28.
3
Assessment of the Potential Ecotoxicological Effects of Pharmaceuticals in the World's Rivers.评估世界河流中药物的潜在生态毒理学效应。
Environ Toxicol Chem. 2022 Aug;41(8):2008-2020. doi: 10.1002/etc.5355. Epub 2022 Jun 22.
4
Prioritization of pharmaceuticals based on risks to aquatic environments in Kazakhstan.基于哈萨克斯坦水生环境风险的药品优先排序。
Integr Environ Assess Manag. 2017 Sep;13(5):832-839. doi: 10.1002/ieam.1895. Epub 2017 Mar 24.
5
Human health risk assessment of the mixture of pharmaceuticals in Dutch drinking water and its sources based on frequent monitoring data.基于频繁监测数据的荷兰饮用水及其源水中药物混合的人体健康风险评估。
Sci Total Environ. 2014 Oct 15;496:54-62. doi: 10.1016/j.scitotenv.2014.07.022. Epub 2014 Jul 22.
6
Modeling pharmaceutical emissions and their toxicity-related effects in life cycle assessment (LCA): A review.建模药物排放及其在生命周期评价(LCA)中的毒性相关效应:综述。
Integr Environ Assess Manag. 2019 Jan;15(1):6-18. doi: 10.1002/ieam.4100. Epub 2018 Nov 14.
7
Pharmaceutical Pollution of the English National Parks.英国国家公园的药物污染。
Environ Toxicol Chem. 2024 Nov;43(11):2422-2435. doi: 10.1002/etc.5973. Epub 2024 Aug 13.
8
Screening and human health risk assessment of pharmaceuticals and their transformation products in Dutch surface waters and drinking water.荷兰地表水中的药品及其转化产物的筛选和人体健康风险评估及饮用水
Sci Total Environ. 2012 Jun 15;427-428:70-7. doi: 10.1016/j.scitotenv.2012.04.010. Epub 2012 May 1.
9
Evaluating the extent of pharmaceuticals in surface waters of the United States using a National-scale Rivers and Streams Assessment survey.利用全国范围的河流与溪流评估调查评估美国地表水中药物的含量。
Environ Toxicol Chem. 2016 Apr;35(4):874-81. doi: 10.1002/etc.3161. Epub 2015 Nov 12.
10
Exploiting monitoring data in environmental exposure modelling and risk assessment of pharmaceuticals.利用监测数据进行药物环境暴露模拟和风险评估。
Environ Int. 2014 Dec;73:176-85. doi: 10.1016/j.envint.2014.07.018. Epub 2014 Aug 13.

引用本文的文献

1
Development and validation of a green/blue UHPLC-MS/MS method for trace pharmaceutical monitoring.一种用于痕量药物监测的绿色/蓝色超高效液相色谱-串联质谱法的开发与验证
Sci Rep. 2025 Aug 22;15(1):30902. doi: 10.1038/s41598-025-15614-4.
2
Chemical Upcycling of Expired Pharmaceuticals as a Source of Value-Added Chemicals for Organic Synthesis and Medicinal Chemistry.过期药物的化学升级转化为有机合成和药物化学中增值化学品的来源。
Molecules. 2024 Oct 11;29(20):4811. doi: 10.3390/molecules29204811.

本文引用的文献

1
Transformation products of pharmaceuticals in the environment: Their fate, (eco)toxicity and bioaccumulation potential.环境中药物的转化产物:它们的命运、(生态)毒性和生物蓄积潜力。
Sci Total Environ. 2022 Jan 1;802:149916. doi: 10.1016/j.scitotenv.2021.149916. Epub 2021 Aug 27.
2
Ecotoxicological effects, environmental fate and risks of pharmaceutical and personal care products in the water environment: A review.水环境中药品和个人护理产品的生态毒理学效应、环境归宿及风险:综述
Sci Total Environ. 2021 Sep 20;788:147819. doi: 10.1016/j.scitotenv.2021.147819. Epub 2021 May 18.
3
Ecological Risk Assessment of Pharmaceuticals in the Transboundary Vecht River (Germany and The Netherlands).
跨界河流(德国和荷兰)中药物的生态风险评估。
Environ Toxicol Chem. 2022 Mar;41(3):648-662. doi: 10.1002/etc.5062. Epub 2021 May 28.
4
Occurrence of carbamazepine, diclofenac, and their related metabolites and transformation products in a French aquatic environment and preliminary risk assessment.法国水生环境中卡马西平、双氯芬酸及其相关代谢物和转化产物的出现情况及初步风险评估。
Water Res. 2021 May 15;196:117052. doi: 10.1016/j.watres.2021.117052. Epub 2021 Mar 15.
5
Geo-referenced simulation of pharmaceuticals in whole watersheds: application of GREAT-ER 4.1 in Germany.地理参考模拟整个流域的药品:在德国应用 GREAT-ER 4.1。
Environ Sci Pollut Res Int. 2021 May;28(17):21926-21935. doi: 10.1007/s11356-020-12189-7. Epub 2021 Jan 7.
6
PubChem in 2021: new data content and improved web interfaces.PubChem 在 2021 年:新增数据内容和改进的网络界面。
Nucleic Acids Res. 2021 Jan 8;49(D1):D1388-D1395. doi: 10.1093/nar/gkaa971.
7
Occurrence and risk assessment of pharmaceutically active compounds in water supply systems in Brazil.水中药物活性化合物在巴西供水系统中的出现及风险评估。
Sci Total Environ. 2020 Dec 1;746:141011. doi: 10.1016/j.scitotenv.2020.141011. Epub 2020 Jul 23.
8
Guidance on harmonised methodologies for human health, animal health and ecological risk assessment of combined exposure to multiple chemicals.关于多种化学品联合暴露对人类健康、动物健康和生态风险评估的统一方法指南。
EFSA J. 2019 Mar 25;17(3):e05634. doi: 10.2903/j.efsa.2019.5634. eCollection 2019 Mar.
9
The grey water footprint of human and veterinary pharmaceuticals.人类和兽用药品的灰水足迹。
Water Res X. 2020 Jan 16;7:100044. doi: 10.1016/j.wroa.2020.100044. eCollection 2020 May 1.
10
Widespread monitoring of chiral pharmaceuticals in urban rivers reveals stereospecific occurrence and transformation.城市河流中手性药物的广泛监测揭示了立体特异性的发生和转化。
Environ Int. 2020 May;138:105657. doi: 10.1016/j.envint.2020.105657. Epub 2020 Mar 30.